Your browser doesn't support javascript.
Highlights of the 13th Japan Bioanalysis Forum Symposium.
Yamaguchi, Takeru; Nishiguchi, Yumi; Yamada, Naohito; Takahashi, Makoto; Uchiyama, Hitoshi; Niwa, Makoto; Koseki, Nozomu; Nakamura, Takahiro; Shimizu, Hisao; Komaba, Junji; Arakawa, Tomoko; Murao, Naoaki.
  • Yamaguchi T; Sumika Chemical Analysis Service, Ltd, Osaka, Osaka, 554-0022, Japan.
  • Nishiguchi Y; CMIC Pharma Science Co., Ltd, Nishiwaki, Hyogo, 677-0032, Japan.
  • Yamada N; Japan Tobacco Inc., Yokohama, Kanagawa, 236-0004, Japan.
  • Takahashi M; Daiichi Sankyo Co., Ltd, Chuo-ku, Tokyo, 140-8710, Japan.
  • Uchiyama H; Towa Pharmaceutical Co., Ltd, Kyoto, Kyoto, 600-8813, Japan.
  • Niwa M; Nippon Shinyaku Co., Ltd, Kyoto, Kyoto, 601-8550, Japan.
  • Koseki N; Kyorin Pharmaceutical Co., Ltd, Nogi-machi, Tochigi, 329-0114, Japan.
  • Nakamura T; Shin Nippon Biomedical Laboratories Ltd, Drug Safety Research Laboratories, Kagoshima, Kagoshima, 891-1394, Japan.
  • Shimizu H; Takeda Pharmaceutical Co., Ltd, Fujisawa-shi, Kanagawa, 251-8555, Japan.
  • Komaba J; Ono Pharmaceutical Co., Ltd, Tsukuba, Ibaraki, 300-4247, Japan.
  • Arakawa T; Pfizer R&D Japan G.K., Shibuya-ku, Tokyo, 151-8589, Japan.
  • Murao N; Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka, 412-8513, Japan.
Bioanalysis ; 14(19): 1251-1255, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2202152
ABSTRACT
Approximately 280 people from pharmaceutical industries, contractors, academic institutions and regulatory authorities attended the 13th Japan Bioanalysis Forum Symposium. The symposium was held via web to prevent the spread of COVID-19 from the 28 February to 2 March 2022. The theme of the symposium was 'All for One Goal', and the event has provided an opportunity for open discussion among researchers with different backgrounds but who share a common goal "to deliver more effective and safe pharmaceuticals to patients as quickly as possible". The speakers focused on hot topics in bioanalysis, including chromatography, biomarker analysis, cell and gene therapy, COVID-19 and antidrug antibody. This symposium provided a great opportunity for the participants to have meaningful discussions, even though 'on the web' was a limited space.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Country/Region as subject: Asia Language: English Journal: Bioanalysis Year: 2022 Document Type: Article Affiliation country: Bio-2022-0191

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Country/Region as subject: Asia Language: English Journal: Bioanalysis Year: 2022 Document Type: Article Affiliation country: Bio-2022-0191